DMKPQ
Price:
$0.0001
Market Cap:
$1.01K
DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company's lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was former...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1995-08-14
Stock Exchange
OTC
Ticker
DMKPQ
According to DMK Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.98% compared to the average of -0.09 of the last 4 quarters.
The mean historical PE Ratio of DMK Pharmaceuticals Corporation over the last ten years is -0.22. The current -0.00 PE Ratio has changed -99.20% with respect to the historical average. Over the past ten years (40 quarters), DMKPQ's PE Ratio was at its highest in in the June 2023 quarter at -0.02. The PE Ratio was at its lowest in in the June 2021 quarter at -0.44.
Average
-0.22
Median
-0.19
Minimum
-0.49
Maximum
-0.08
Discovering the peaks and valleys of DMK Pharmaceuticals Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 149.64%
Maximum Annual PE Ratio = -0.08
Minimum Annual Increase = -53.85%
Minimum Annual PE Ratio = -0.49
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.10 | -49.79% |
| 2021 | -0.19 | 149.64% |
| 2020 | -0.08 | -43.23% |
| 2019 | -0.14 | -39.94% |
| 2018 | -0.23 | -53.85% |
| 2017 | -0.49 | 72.19% |
The current PE Ratio of DMK Pharmaceuticals Corporation (DMKPQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.12
5-year avg
-0.15
10-year avg
-0.22
DMK Pharmaceuticals Corporation’s PE Ratio is less than IMV Inc. (-0.00), greater than BioELife Corp. (-0.00), greater than Millennium Sustainable Ventures Corp. (-0.00), less than eFFECTOR Therapeutics, Inc. (-0.00), less than HLK Biotech Holding Group, Inc. (0), less than ContraFect Corporation (-0.00), less than BIMI International Medical Inc. (-0.00), greater than Minerva Surgical, Inc. (-0.00), greater than American Medical Technologies Inc. (-0.00), greater than Omnimmune Holdings, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $117.00 | |
| -0.00 | $1.88K | |
| -0.00 | $2.26K | |
| -0.00 | $941.00 | |
| 0 | $925.00 | |
| -0.00 | $1.07K | |
| -0.00 | $1.16K | |
| -0.00 | $8.88K | |
| -0.00 | $1.03K | |
| -0.00 | $981.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DMK Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DMK Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is DMK Pharmaceuticals Corporation's PE Ratio?
How is the PE Ratio calculated for DMK Pharmaceuticals Corporation (DMKPQ)?
What is the highest PE Ratio for DMK Pharmaceuticals Corporation (DMKPQ)?
What is the 3-year average PE Ratio for DMK Pharmaceuticals Corporation (DMKPQ)?
What is the 5-year average PE Ratio for DMK Pharmaceuticals Corporation (DMKPQ)?
How does the current PE Ratio for DMK Pharmaceuticals Corporation (DMKPQ) compare to its historical average?